Autolus Therapeutics plc (AUTL) Free cash flow 2016–2025
Autolus Therapeutics plc (AUTL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$302.6MFY2025 · since FY2016: -$11.7M → -$302.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$302.6M | -32.5% |
| FY2024 | -$228.3M | -45.8% |
| FY2023 | -$156.6M | -27.1% |
| FY2022 | -$123.1M | +2.8% |
| FY2021 | -$126.7M | +4.3% |
| FY2020 | -$132.4M | -10.5% |
| FY2019 | -$119.8M | -194.7% |
| FY2018 | -$40.7M | -111.4% |
| FY2017 | -$19.2M | -64.4% |
| FY2016 | -$11.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice